We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Extended Release Melatonin

Circadian rhythm support; safety screen: pregnancy without clinician guidance; sedatives; next day drowsiness risk.

Use extra caution — Safety evidence: extended release may prolong exposure and next day drowsiness, but formulation specific comparative safety evidence is limited. Details

Last reviewed: Report a correctionProfile-wide ·D Preliminary
Extended Release Melatonin monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade D
Safety
Safety evidence: extended release may prolong exposure and next-day drowsiness, but formulation-specific comparative safety evidence is limited.
Profile context
melatonin receptors, suprachiasmatic nucleus
Next steps

Continue reading

Quick stats

Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
Melatonin Receptors, Suprachiasmatic Nucleus

Safety

Safety & Cautions

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Safety evidence
extended release may prolong exposure and next-day drowsiness, but formulation-specific comparative safety evidence is limited
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
Talk to a professional if
you are pregnant or breastfeeding.

Headache and dizziness occur in melatonin trials; driving, concurrent sedatives, pregnancy, breastfeeding, pediatric use, and chronic use require individualized review.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — MT1/MT2 Receptor Mediated Circadian Regulation · Circadian Phase Timing Support · Hormonal Signaling Context

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — Safety evidence: extended release may prolong exposure and next day drowsiness, but formulation specific comparative safety evidence is limited.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Extended Release Melatonin has a preliminary evidence rating.

Sleep SupportSleep
Effects
2
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Extended Release Melatonin Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Extended Release Melatonin Works

How Extended Release Melatonin WorksExtended Release Melatonin acts on biological target pathways via hormonal signaling (context), leading to melatonin receptors.Extended Release MelatoninBiological TargetBiological pathwayHormonal SignalingContextMelatonin ReceptorsObservable outcomeSerotoninModulation
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
capsule or standardized extract
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • MT1/MT2 Receptor Mediated Circadian Regulation
  • Circadian Phase Timing Support
  • Hormonal Signaling Context
  • Sleep Maintenance Signaling

Guides that use Extended Release Melatonin

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Extended Release Melatonin evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?